ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
即将进行的临床试验
-
Intuitive Surgical尚未招聘
-
University of Alabama at Birmingham尚未招聘Spinal Cord Disorders美国
-
Medical University of Vienna尚未招聘血管通路 | 血管通路并发症 | 透析导管感染 | 血液透析 | 血液透析并发症 | 透析通路功能障碍 | ESRD(终末期肾病) | 透析导管奥地利
-
NYU Langone HealthNational Cancer Institute (NCI)尚未招聘
-
M.D. Anderson Cancer Center尚未招聘
-
Prevention Strategies, LLCNational Institute on Drug Abuse (NIDA); NORC at the University of Chicago尚未招聘酒精相关疾病 | 烟草使用障碍 | 吸食大麻 | 物质相关疾病
-
Second Affiliated Hospital of Nanchang UniversityBeijing Pearl Biotechnology Limited Liability Company招聘中
-
Ming Liu尚未招聘
-
The First Affiliated Hospital of Soochow University尚未招聘
-
Peking University First HospitalPeking University Shenzhen Hospital尚未招聘老年患者 | 癌症手术 | 有针对性的温度管理 | 体温过低,意外 | 神经认知恢复延迟中国
Clinical Research Jobs
-
United Kingdom - London
-
United States - Reno
-
United States - North Carolina - Durham
-
Poland - Krakow
-
Japan - Tokyo
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China